The pharmacokinetics of ofloxacin were studied in six healthy volunteers following a 600 mg oral dose. The concentration of the compound was measured in serum, inflammatory fluid and urine. Ofloxacin was rapidly absorbed, the mean maximum concentration of ofloxacin being 10·7 rngjl at 1·2 h. The mean serum elimination half-life was 7 hand 80·3 % of the administered compound was recovered in the urine by 48 h. Ofloxacin penetrated the inflammatory fluid well, the mean peak level being 5·2 mg/l at 5·3 h. A review of the tissue penetration is presented which indicates that the high volume of distribution of ofloxacin is associated with good tissue penetration
Pharmacokinetics and urinary excretion of an intravenous dose of 5 mg.kg–1 ofloxacin were investigat...
The influence of experimentally Escherichia coli-induced fever (EEIF) on the pharmacokinetics of ofl...
Two levofloxacin administration regimens were used for six healthy male volunteers. They received ei...
The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, fo...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
In ten volunteers the pharmacokinetics of ofloxacin and ciprofloxacin were determined after crossove...
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norf...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
The bioequivalence of oral and intravenous ofloxacin was investigated after the administration of mu...
The bioavailability of two ofloxacin (OFX) tablet formulations (OTT, test formulation from Laborator...
A study was performed to establish the effect of A13+ and Fe24 cations on the absorption of ofloxaci...
The pharmacokinetics and tissue penetration of five quinolones into inflammatory exudate were studie...
Objective: To study the pharmacokinetics of ofloxacin using salivary drug concentration when adminis...
The penetration of ofloxacin (OFLX) into prostatic tissue was examined on 11 patients with benign pr...
OBJECTIVE: To evaluate the pharmacokinetic profile of ofloxacin in healthy volunteers after single ...
Pharmacokinetics and urinary excretion of an intravenous dose of 5 mg.kg–1 ofloxacin were investigat...
The influence of experimentally Escherichia coli-induced fever (EEIF) on the pharmacokinetics of ofl...
Two levofloxacin administration regimens were used for six healthy male volunteers. They received ei...
The pharmacokinetics of the 4-quinolone agent, ofloxacin, were studied in six healthy volunteers, fo...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
In ten volunteers the pharmacokinetics of ofloxacin and ciprofloxacin were determined after crossove...
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norf...
The safety and pharmacokinetics of ofloxacin in 48 healthy male volunteers were studied in a two-cen...
The bioequivalence of oral and intravenous ofloxacin was investigated after the administration of mu...
The bioavailability of two ofloxacin (OFX) tablet formulations (OTT, test formulation from Laborator...
A study was performed to establish the effect of A13+ and Fe24 cations on the absorption of ofloxaci...
The pharmacokinetics and tissue penetration of five quinolones into inflammatory exudate were studie...
Objective: To study the pharmacokinetics of ofloxacin using salivary drug concentration when adminis...
The penetration of ofloxacin (OFLX) into prostatic tissue was examined on 11 patients with benign pr...
OBJECTIVE: To evaluate the pharmacokinetic profile of ofloxacin in healthy volunteers after single ...
Pharmacokinetics and urinary excretion of an intravenous dose of 5 mg.kg–1 ofloxacin were investigat...
The influence of experimentally Escherichia coli-induced fever (EEIF) on the pharmacokinetics of ofl...
Two levofloxacin administration regimens were used for six healthy male volunteers. They received ei...